Arthritis, Rheumatoid: all 2,962 studies
Page 29 of 30. Open to participants first (396), then studies with results posted, then the rest; newest registration first within each.
- Treatment of Arthritis With Syk Kinase Inhibition (TASKI-1)CompletedNCT00326339Phase 2
- Pharmacogenomics of Anti-TNF (Anti-tumor Necrosis Factor) Treatment in Patients With Rheumatoid ArthritisStatus unknownNCT00321217
- SB-681323 In Subjects With Rheumatoid ArthritisCompletedNCT00320450Phase 2
- A Double Blind Placebo Controlled Study to Assess the Efficacy on Joint Damage in RA PatientsCompletedNCT00319917Phase 4
- Open-label, Pilot Protocol of Patients With Rheumatoid Arthritis Who Switch to Infliximab After Incomplete Response to EtanerceptCompletedNCT00317538Phase 3
- A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate TherapyCompletedNCT00316771Phase 2
- A Study of P38 Inhibitor (4) Monotherapy in Patients With Active Rheumatoid ArthritisCompletedNCT00303563Phase 2
- Assessment of Safety, Pharmacokinetics and Efficacy in a Combination Treatment With SMP-114TerminatedNCT00296257Phase 2
- A Multiple Dose Study to Evaluate Subcutaneous AMG 108 in Subjects With Rheumatoid ArthritisCompletedNCT00293826Phase 2
- Dose-Escalating Study of BG9924 in Combination With Methotrexate in Active Rheumatoid ArthritisCompletedNCT00292422Phase 2
- HuMax-CD20 in Active Rheumatoid Arthritis, Phase I/IICompletedNCT00291928Phase 2
- Primary TKA Cruciate Retaining vs Cruciate Substituting With Rotating Platform Knee ProsthesesTerminatedNCT00289081Not applicable
- Quality of Sleep in Patients With Rheumatoid ArthritisStatus unknownNCT00287794
- RAHelp.Org: An Online Self Management Program for Adults With Rheumatoid ArthritisCompletedNCT00283855Not applicable
- A Phase 2 Study to Evaluate the Safety, Tolerability, and Activity of Fontolizumab in Subjects With Active Rheumatoid ArthritisTerminatedNCT00281294Phase 2
- Leflunomide in Rheumatoid ArthritisCompletedNCT00280644Phase 4
- Phase I/II Multiple-Dose LEA29Y vs CTLAG4Ig vs Placebo in Rheumatoid ArthritisCompletedNCT00279760Phase 1/2
- Vaccination Study of Abatacept (BMS-188667) for Normal Healthy VolunteersCompletedNCT00279734Phase 1
- Vitamin D Deficiency Causes Immune Dysfunction and Enables or Perpetuates the Development of Rheumatoid ArthritisWithdrawnNCT00279461Phase 2
- Stem Cell Support in Patients With Rheumatoid ArthritisTerminatedNCT00278551Phase 1
- Role of DcR3 in T Cell Activation in SLE and RAStatus unknownNCT00275899
- Ramipril in Rheumatoid ArthritisCompletedNCT00273533Phase 2/3
- Infliximab Plus Methotrexate for the Treatment of Rheumatoid ArthritisCompletedNCT00269867Phase 3
- Study Evaluating the Clinical Remission in Early Aggressive Rheumatoid ArthritisCompletedNCT00267852
- A Long-term Safety Study of Infliximab (Remicade)CompletedNCT00261976
- Single Dose Study Of GW856553 On A Protein That Is An Indicator For Rheumatoid Arthritis (RA)CompletedNCT00256919Phase 2
- Study Evaluating the Combination of Etanercept and Methotrexate in Rheumatoid Arthritis SubjectsCompletedNCT00252668Phase 4
- A Study to Evaluate the Safety of an Investigational Drug (Etoricoxib) in Patients With Osteoarthritis (OA) or Rheumatoid Arthritis (RA)(0663-066)CompletedNCT00250445Phase 3
- Enbrel Liquid Immunogenicity ProtocolCompletedNCT00249041Phase 3
- Improving Motivation for Physical Activity in Arthritis Clinical TrialCompletedNCT00248105Not applicable
- ULTRACET (Tramadol Hydrochloride and Acetaminophen) for the Treatment of Rheumatoid Arthritis Pain.CompletedNCT00246168Phase 4
- The Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) ProtocolCompletedNCT00246064Phase 4
- Study Evaluating Enbrel in Patients With Rheumatoid ArthritisCompletedNCT00245934
- Study Comparing Enbrel (Etanercept) Plus Methotrexate Versus Enbrel Alone in Active Rheumatoid Arthritis Despite Current Methotrexate TherapyCompletedNCT00244556Phase 4
- A Study To Investigate Markers Of Inflammation In Rheumatoid ArthritisCompletedNCT00242853
- Long-Circulating Liposomal Prednisolone Versus Pulse Intramuscular Methylprednisolone in Patients With Active Rheumatoid ArthritisCompletedNCT00241982Phase 2
- Long-term Observation of Patients With Early Rheumatoid ArthritisCompletedNCT00240136
- A Study to Compare Meloxicam IM Once Daily Versus Meloxicam Orally Once Daily in Patients With Rheumatoid ArthritisCompletedNCT00239382Phase 3
- Randomized, Double-blind, Placebo-controlled Study to Assess Fatigue in Patients With ACD Due to RA Receiving PROCRITTerminatedNCT00236678Phase 2
- A Safety and Efficacy Study for Infliximab (Remicade) With Methotrexate in Patients With Early Rheumatoid ArthritisCompletedNCT00236028Phase 3
- Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With MethotrexateCompletedNCT00235859Phase 3
- Quality of Life Study With Adalimumab in Rheumatoid ArthritisCompletedNCT00234936Phase 3
- Efficacy of HUMIRA in Subjects With Active Rheumatoid ArthritisCompletedNCT00234897Phase 4
- Adalimumab in Combination With Methotrexate vs Methotrexate Alone in Early Rheumatoid ArthritisCompletedNCT00234845Phase 3
- Predictors of the Response to Adalimumab in Rheumatoid ArthritisCompletedNCT00234234Phase 4
- A Long Term Roll-over Study to Investigate the Efficacy and Safety of Adalimumab Given Long-term to Patients With Rheumatoid ArthritisCompletedNCT00233571Phase 3
- Open-Label Steroid Reduction Study of Adalimumab With Methotrexate in Patients With Active Rheumatoid ArthritisTerminatedNCT00233558Phase 4
- Medical In-Patient Rehabilitation in Rheumatoid ArthritisCompletedNCT00229541Phase 3
- Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Rheumatoid ArthritisCompletedNCT00221000Phase 2
- Comparison of Adalimumab and Infliximab Treatment of Rheumatoid ArthritisStatus unknownNCT00216177Phase 4
- Gene Expression Profiling in PBMCs as a Tool for Prediction of Infliximab Responsiveness in Rheumatoid ArthritisCompletedNCT00213564
- Gene Expression Profiling in PBMCs as a Tool for Prediction of Anakinra Responsiveness in Rheumatoid ArthritisCompletedNCT00213538
- Methotrexate and Cyclosporine in Treatment of Early Rheumatoid ArthritisCompletedNCT00209859Phase 4
- Phase 2 Clinical Study in Rheumatoid Arthritis With an Investigational Oral p38 MAP Kinase Inhibitor VX-702CompletedNCT00205478Phase 2
- A Placebo-Controlled, Double-Blinded, Randomized Trial of Remicade in Korean Patients With Rheumatoid Arthritis Despite Methotrexate (Study P04280)(COMPLETED)CompletedNCT00202852Phase 3
- Study Evaluating Etanercept in Patients With Rheumatoid Arthritis(RA), Juvenile Idiopathic Arthritis (JIA), or Psoriatic Arthritis (PsA) in SpainCompletedNCT00195377
- Study Evaluating Etanercept in Patients With Rheumatoid Arthritis Who Completed Trial 0881A1-301-EU in SpainCompletedNCT00195364
- Assessing the Suitability of an Imaging Probe for Use in Clinical Cell and Gene Therapy Trials in Cancer and Rheumatoid ArthritisCompletedNCT00185848Phase 1
- Decoy Receptor 3 (DcR3) Polymorphisms in Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE)Status unknownNCT00172666
- 6 Week Open-label Trial With Lumiracoxib 200mg o.d. in Primary Knee Osteoarthritis or Rheumatoid ArthritisCompletedNCT00170872Phase 3
- Multiple Ascending Dose Study of BMS-582949 in Patients With Stable Rheumatoid Arthritis on the Methotrexate BackgroundCompletedNCT00162292Phase 1
- The Study of Abatacept in Combination With EtanerceptCompletedNCT00162279Phase 2
- An Exploratory Study of Changes in Synovial Immune Responses Following BMS-188667 Therapy in Subjects With Active Rheumatoid Arthritis on Background DMARDs Who Have Failed Anti-TNF TherapyCompletedNCT00162201Phase 1
- A Study of Liquid Certolizumab Pegol as Additional Medication to Methotrexate in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid ArthritisCompletedNCT00160602Phase 3
- A Study of Rofecoxib Versus Naproxen in the Treatment of Chinese Patient With Rheumatoid Arthritis (0966-231)CompletedNCT00157872Phase 4
- Develop Biomarkers for Assessing RA Joint ErosionStatus unknownNCT00154947
- A Study of Imatinib 400 mg Once Daily in Combination With Methotrexate in the Treatment of Rheumatoid Arthritis.CompletedNCT00154336Phase 2
- A Placebo Controlled Study to Assess Efficacy and Safety of Certolizumab Pegol in the Treatment of Rheumatoid ArthritisCompletedNCT00152386Phase 3
- Prevention of Ectopic Bone Related Pain and Disability After Hip Replacement Surgery With Peri-Operative IbuprofenCompletedNCT00145730Phase 4
- Study of MRA in Patients With Rheumatoid Arthritis (RA)CompletedNCT00144651Phase 2
- Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA220JP or MRA221JPCompletedNCT00144586Phase 3
- Clinical Pharmacology Study of MRA in Patient With Rheumatoid Arthritis (RA) With Renal ImpairmentCompletedNCT00144573Not applicable
- Drug-Drug Interaction Study of MRA in Patient With Rheumatoid Arthritis (RA)CompletedNCT00144560Not applicable
- Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA012JPCompletedNCT00144547Phase 3
- Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA213JPCompletedNCT00144534Phase 3
- Comparative Study (Double-Blind) of MRA for Rheumatoid Arthritis (RA)CompletedNCT00144521Phase 3
- Phase III Comparative Study(Open-Label) of MRA for Rheumatoid Arthritis(RA)CompletedNCT00144508Phase 3
- A Multicentre Trial to Determine the Efficacy of AD 452 in RA Subjects.CompletedNCT00141934Phase 2
- Study Evaluating ERB-041 With Methotrexate in Rheumatoid ArthritisCompletedNCT00141830Phase 2
- A Single Dose Of Compound SB-681323 Compared To Prednisolone On A Protein That Is an Indicator For Rheumatoid ArthritisCompletedNCT00134693Phase 2
- Study of Enbrel in Rheumatoid Arthritis (RA) Subjects With Comorbid DisordersCompletedNCT00132418Phase 4
- Study of Intra-articular Delivery of tgAAC94 in Inflammatory Arthritis SubjectsCompletedNCT00126724Phase 1/2
- Study of People With Rheumatoid Arthritis Who Require Joint Surgery in the HandCompletedNCT00124254Not applicable
- Open-Label Extension Safety Study of PROCRIT in Patients With Anemia of Chronic Disease Due to Rheumatoid ArthritisWithdrawnNCT00123149Phase 2
- REKinDLE: Registry With Enbrel® or Kineret® in a Database Using Longitudinal EvaluationsCompletedNCT00121056
- Evaluating Kineret® (Anakinra) in Rheumatoid Arthritis (RA) Subjects Using aSelf-Reported QuestionnaireCompletedNCT00121043Phase 4
- Anakinra (Kineret®) in Combination With Disease Modifying Anti-Rheumatic Drugs (DMARDS) in Subjects With Active Rheumatoid Arthritis (RA)CompletedNCT00117091Phase 3
- Rheumatoid Arthritis DMARD Intervention and UtilizationStudyCompletedNCT00116727
- Rheumatoid Arthritis (DMARD) Intervention and UtilizationStudyCompletedNCT00116714
- Evaluating Efficacy and Safety of Etanercept 50 mg Twice Weekly (BIW) in Rheumatoid Arthritis (RA) Subjects Who Are Sub-Optimal Responders to Etanercept 50 mg Once Weekly (QW)CompletedNCT00115219Phase 4
- COX-2 Inhibitor Study In Patients With Rheumatoid ArthritisCompletedNCT00113308Phase 3
- Evaluating the Safety of Extended Treatment With Pegsunercept (PEG sTNF-RI)in Subjects With Rheumatoid Arthritis (RA)CompletedNCT00111423Phase 2
- Evaluating the Effect of Anakinra (r-metHuIL-1ra) on Vaccine AntibodyResponse in Subjects With Rheumatoid Arthritis (RA)CompletedNCT00111410Phase 4
- Treatment for Subjects With Active Rheumatoid Arthritis (RA)CompletedNCT00110903Phase 3
- Effects of Pulsed Magnetic Pads on Rheumatoid Arthritis Symptoms in Postmenopausal WomenCompletedNCT00110565Phase 2
- A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid ArthritisCompletedNCT00109408Phase 3
- A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid ArthritisCompletedNCT00106574Phase 3
- A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid ArthritisCompletedNCT00106548Phase 3
- A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate TherapyCompletedNCT00106522Phase 3
- Efficacy Study of MM-093 in Rheumatoid Arthritis Patients on Methotrexate (MTX)CompletedNCT00105976Phase 2